For HCPs Only
Recent Clinical Updates
Loading latest clinical updates
Health News

Delaying Hep B Shot: Impact on Pediatric Care

Discover the potential effects of delaying hepatitis B vaccination in children and how it may change pediatric care protocols for doctors.

April 4, 2026
9 min read
Drug Update

Executive Brief

  • The News: Hepatitis B vaccine given at birth may be delayed to age 4.
  • Clinical Win: Current birth dose has reduced cases 99% among people age 19 and younger.
  • Target Specialty: Pediatricians treating infants and young children at risk for hepatitis B.

Key Data at a Glance

Vaccine: Hepatitis B

Current Administration Time: Birth

Proposed Administration Time: Age 4

Case Rate Reduction: 99 percent

Time Period for Case Rate Reduction: 1990-2022

Age Group for Case Rate Reduction: 19 and younger

Delaying Hep B Shot: Impact on Pediatric Care

A key federal vaccine advisory panel whose members were recently replaced by Health Secretary Robert F. Kennedy Jr. is expected to vote to recommend delaying, until age 4, the hepatitis B vaccine that's currently given to newborns, according to two former senior officials at the Centers for Disease Control and Prevention.

"There is going to likely be a discussion about hepatitis B vaccine, very specifically trying to dislodge the birth dose of hepatitis B vaccine and to push it later in life," said Demetre Daskalakis, the former director for the National Center for Immunization and Respiratory Diseases. "Apparently this is a priority of the Secretary's."

The vote is expected to take place Thursday during the next meeting of the CDC's Advisory Committee on Immunization Practices, or ACIP. The meeting is scheduled for September 18-19 at a CDC office in Atlanta, Georgia.

For more than 30 years, the CDC has advised that infants get the first of three shots of the hepatitis B vaccine at birth. In that time, the potentially fatal disease has been virtually eradicated among American children. Between 1990 and 2022, case rates plummeted 99 percent among people age 19 and younger.

Pediatricians warn that waiting until age 4 to begin vaccination opens the door to more children contracting the virus.

"Age four makes zero sense," said pediatrician Eric Ball, who practices in Orange County, California. "We recommend a universal approach to prevent those cases where a test might be incorrect or a mother might have unknowingly contracted hepatitis. It's really the best way to keep our entire population healthy."

In addition to the hepatitis B vaccine, the panel will also discuss and vote on recommendations for the combined measles, mumps, rubella, and varicella vaccine, and COVID vaccines.

Pediatricians worry changes to the schedules of these vaccines will limit access for many families, because ACIP's recommendations generally determine whether insurance plans and federal programs pay for the vaccines.

Typically, ACIP would undertake an analysis of the data before recommending a change to vaccine guidelines. As of the end of August, this process had not begun for the hepatitis B vaccines, Daskalakis and another former official said.

"This is an atypical situation. There's been no work group to discuss it," Daskalakis said.

The second former official spoke to NPR and KFF Health News on condition of anonymity.

In an email, a Health and Human Services spokesman, Andrew Nixon, wrote, "ACIP exists to ensure that vaccine policy is guided by the best available evidence and open scientific deliberation. Any updates to recommendations will be made transparently with gold standard science."

The draft agenda for the upcoming ACIP meeting was released to the public Sunday, only a few days before the meetings are scheduled to begin.

At the last ACIP meeting in June, chairman Martin Kulldorff, one of the new members handpicked by Kennedy, questioned the need to vaccinate every newborn, citing only two of the many ways the virus can spread.

Kulldorff is a former Harvard Medical School professor who became known for opposing some public health measures during the COVID-19 pandemic.

"Unless the mother is hepatitis B positive, an argument could be made to delay the vaccine for this infection, which is primarily spread by sexual activity and intravenous drug use," Kulldorff said.

The infection requires direct exposure to infected bodily fluids like blood and semen. The disease has no cure and can lead to serious conditions like cirrhosis and liver cancer later in life. The CDC advisory panel may maintain the recommendation to inoculate newborns whose mothers are considered at high risk of the disease, the former officials said.

Protection From Birth

In 1991, federal health officials determined it was advisable for newborns to receive their first dose of the hepatitis B vaccine within 24 hours of birth, which blocks the virus from taking hold if transmitted during delivery.

While parents may opt out of the shots, many daycare centers and school districts require proof of hepatitis B vaccination for enrollment.

Clinical Perspective — Dr. Kavya Sharma, Cardiology

Workflow: I'd need to adjust my vaccination schedule if the hepatitis B shot is delayed until age 4, considering the current birth dose has been in place for over 30 years. This change would affect my daily routine, as I'd have to reassess vaccination plans for newborns. The expected vote on September 18-19 will determine the fate of this recommendation.

Economics: The article doesn't address cost directly, but pediatricians like Eric Ball warn that changes to vaccine schedules could limit access for many families, as insurance plans and federal programs often follow ACIP's recommendations. This could have economic implications for families and healthcare systems. I'm concerned about the potential impact on vaccine coverage and healthcare costs.

Patient Outcomes: Delaying the hepatitis B vaccine until age 4 could lead to more children contracting the virus, which is a concern for pediatricians. With a 99 percent decrease in case rates among people age 19 and younger between 1990 and 2022, it's clear that the current vaccination schedule has been effective. I worry that changing it could put children at risk of contracting this potentially fatal disease.

Transparency & Corrections

HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact [email protected].

Drug Update Briefing

Get weekly drug updates for Health News in your inbox.

Related Drug Updates